Biology-driven targeted therapy of pediatric soft-tissue and bone tumors : : current opportunities and future challenges / / edited by Thomas G. P. Grünewald and Simone Fulda.
Recent advances in the understanding of the biological basis of pediatric soft-tissue and bone tumors, especially owing to the advent of “omics” technologies, have led to an exponential increase in the current knowledge on the genetic and cellular patho-mechanisms that drive these diseases. This off...
Saved in:
: | |
---|---|
TeilnehmendeR: | |
Place / Publishing House: | Lausanne, Switzerland : : Frontiers Media SA,, 2016. ©2016 |
Year of Publication: | 2016 |
Language: | English |
Series: | Frontiers Research Topics
|
Physical Description: | 1 online resource (147 pages) :; illustrations, charts; digital, PDF file(s). |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993547425904498 |
---|---|
ctrlnum |
(CKB)3710000000631145 (oapen)https://directory.doabooks.org/handle/20.500.12854/42243 (EXLCZ)993710000000631145 |
collection |
bib_alma |
record_format |
marc |
spelling |
Simone Fulda auth Biology-driven targeted therapy of pediatric soft-tissue and bone tumors : current opportunities and future challenges / edited by Thomas G. P. Grünewald and Simone Fulda. Frontiers Media SA 2016 Lausanne, Switzerland : Frontiers Media SA, 2016. ©2016 1 online resource (147 pages) : illustrations, charts; digital, PDF file(s). text txt rdacontent computer c rdamedia online resource cr rdacarrier text file rda Frontiers Research Topics Includes bibliographical references. Open access Unrestricted online access star Recent advances in the understanding of the biological basis of pediatric soft-tissue and bone tumors, especially owing to the advent of “omics” technologies, have led to an exponential increase in the current knowledge on the genetic and cellular patho-mechanisms that drive these diseases. This offers the unprecedented opportunity to develop and implement targeted therapies such as monoclonal antibodies, small molecules, oncolytic viruses, and immunotherapies in standard and/or personalized treatment regimens. However, to date only a few examples document a successful translation of discoveries from the bench to the bedside. Recent international expert congresses such as the “Pediatric Cancer Translational Genomics” conference (Phoenix, Arizona, 2012), the ESF-EMBO workshop on “Molecular Biology and Innovative Therapies in Sarcomas” (Pultusk, Poland, 2012), and the AACR special meeting on “Pediatric Cancer at the Crossroads – Translating Discovery into Improved Outcomes” (San Diego, California, 2013) further emphasize the urgent need for a more rapid and especially more successful translational process. Hence, we strongly believe that a Frontiers Research Topic aiming at this aspect would fit just in time and that it would have great potential to receive numerous contributions of outstanding experts of the field. The proposed Frontiers Research Topic shall provide a platform for active and interdisciplinary discussion, summarize current state-of-the-art knowledge on all basic research and translational aspects in pediatric soft-tissue and bone tumors, and offer new perspectives of how to further promote and accelerate the translational process. We welcome high-quality original research articles, brief reports, as well as opinion, hypothesis, and review articles, and especially encourage submissions from early-career scientists. English Oncology Research. Cancer in children Treatment. targeted therapy Translational research Ewing sarcoma Sarcoma pediatric oncology Osteosarcoma Immunotherapy bone tumor Rhabdomyosarcoma epithelioid sarcoma Grünewald, Thomas, editor. Fulda, Simone, editor. 2-88919-819-7 |
language |
English |
format |
eBook |
author |
Simone Fulda |
spellingShingle |
Simone Fulda Biology-driven targeted therapy of pediatric soft-tissue and bone tumors : current opportunities and future challenges / Frontiers Research Topics |
author_facet |
Simone Fulda Grünewald, Thomas, Fulda, Simone, |
author_variant |
s f sf |
author2 |
Grünewald, Thomas, Fulda, Simone, |
author2_variant |
t g tg s f sf |
author2_role |
TeilnehmendeR TeilnehmendeR |
author_sort |
Simone Fulda |
title |
Biology-driven targeted therapy of pediatric soft-tissue and bone tumors : current opportunities and future challenges / |
title_sub |
current opportunities and future challenges / |
title_full |
Biology-driven targeted therapy of pediatric soft-tissue and bone tumors : current opportunities and future challenges / edited by Thomas G. P. Grünewald and Simone Fulda. |
title_fullStr |
Biology-driven targeted therapy of pediatric soft-tissue and bone tumors : current opportunities and future challenges / edited by Thomas G. P. Grünewald and Simone Fulda. |
title_full_unstemmed |
Biology-driven targeted therapy of pediatric soft-tissue and bone tumors : current opportunities and future challenges / edited by Thomas G. P. Grünewald and Simone Fulda. |
title_auth |
Biology-driven targeted therapy of pediatric soft-tissue and bone tumors : current opportunities and future challenges / |
title_new |
Biology-driven targeted therapy of pediatric soft-tissue and bone tumors : |
title_sort |
biology-driven targeted therapy of pediatric soft-tissue and bone tumors : current opportunities and future challenges / |
series |
Frontiers Research Topics |
series2 |
Frontiers Research Topics |
publisher |
Frontiers Media SA Frontiers Media SA, |
publishDate |
2016 |
physical |
1 online resource (147 pages) : illustrations, charts; digital, PDF file(s). |
isbn |
2-88919-819-7 |
illustrated |
Illustrated |
work_keys_str_mv |
AT simonefulda biologydriventargetedtherapyofpediatricsofttissueandbonetumorscurrentopportunitiesandfuturechallenges AT grunewaldthomas biologydriventargetedtherapyofpediatricsofttissueandbonetumorscurrentopportunitiesandfuturechallenges AT fuldasimone biologydriventargetedtherapyofpediatricsofttissueandbonetumorscurrentopportunitiesandfuturechallenges |
status_str |
c |
ids_txt_mv |
(CKB)3710000000631145 (oapen)https://directory.doabooks.org/handle/20.500.12854/42243 (EXLCZ)993710000000631145 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Biology-driven targeted therapy of pediatric soft-tissue and bone tumors : current opportunities and future challenges / |
author2_original_writing_str_mv |
noLinkedField noLinkedField |
_version_ |
1802341089087062016 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03640cam a22005051i 4500</leader><controlfield tag="001">993547425904498</controlfield><controlfield tag="005">20240619212325.0</controlfield><controlfield tag="006">m fs d </controlfield><controlfield tag="007">cr#mn#---|||||</controlfield><controlfield tag="008">160411s2016 sz ad fob 000 0 eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)3710000000631145</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/42243</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)993710000000631145</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="d">UkMaJRU</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Simone Fulda</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Biology-driven targeted therapy of pediatric soft-tissue and bone tumors :</subfield><subfield code="b">current opportunities and future challenges /</subfield><subfield code="c">edited by Thomas G. P. Grünewald and Simone Fulda.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">Frontiers Media SA</subfield><subfield code="c">2016</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Lausanne, Switzerland :</subfield><subfield code="b">Frontiers Media SA,</subfield><subfield code="c">2016.</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (147 pages) :</subfield><subfield code="b">illustrations, charts; digital, PDF file(s).</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="347" ind1=" " ind2=" "><subfield code="a">text file</subfield><subfield code="2">rda</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Frontiers Research Topics</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="506" ind1=" " ind2=" "><subfield code="a">Open access</subfield><subfield code="f">Unrestricted online access</subfield><subfield code="2">star</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Recent advances in the understanding of the biological basis of pediatric soft-tissue and bone tumors, especially owing to the advent of “omics” technologies, have led to an exponential increase in the current knowledge on the genetic and cellular patho-mechanisms that drive these diseases. This offers the unprecedented opportunity to develop and implement targeted therapies such as monoclonal antibodies, small molecules, oncolytic viruses, and immunotherapies in standard and/or personalized treatment regimens. However, to date only a few examples document a successful translation of discoveries from the bench to the bedside. Recent international expert congresses such as the “Pediatric Cancer Translational Genomics” conference (Phoenix, Arizona, 2012), the ESF-EMBO workshop on “Molecular Biology and Innovative Therapies in Sarcomas” (Pultusk, Poland, 2012), and the AACR special meeting on “Pediatric Cancer at the Crossroads – Translating Discovery into Improved Outcomes” (San Diego, California, 2013) further emphasize the urgent need for a more rapid and especially more successful translational process. Hence, we strongly believe that a Frontiers Research Topic aiming at this aspect would fit just in time and that it would have great potential to receive numerous contributions of outstanding experts of the field. The proposed Frontiers Research Topic shall provide a platform for active and interdisciplinary discussion, summarize current state-of-the-art knowledge on all basic research and translational aspects in pediatric soft-tissue and bone tumors, and offer new perspectives of how to further promote and accelerate the translational process. We welcome high-quality original research articles, brief reports, as well as opinion, hypothesis, and review articles, and especially encourage submissions from early-career scientists.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Oncology</subfield><subfield code="x">Research.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cancer in children</subfield><subfield code="x">Treatment.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">targeted therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Translational research</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Ewing sarcoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Sarcoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pediatric oncology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Osteosarcoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Immunotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bone tumor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Rhabdomyosarcoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">epithelioid sarcoma</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Grünewald, Thomas,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fulda, Simone,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">2-88919-819-7</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2024-06-20 01:31:01 Europe/Vienna</subfield><subfield code="d">00</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2016-04-12 04:07:06 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338570350004498&Force_direct=true</subfield><subfield code="Z">5338570350004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338570350004498</subfield></datafield></record></collection> |